{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:cenvacibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:ebrasodebart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:baloncibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01775462: Phase 2 Interventional Completed X-Linked Hypohidrotic Ectodermal Dysplasia
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:recibokibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:laventatug tivedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:larnefpendekin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:produvofusp [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN